UK half of them are due to head injuries, and half to MOF and ARDS-two conditions in which widespread injury is precipitated by an uncontrolled inflammatory response1.
In some respects the response resembles immunosuppression, in others immunoactivation. The latter has the potential to cause cell-mediated damage in remote organs, and key players in the host response are cytokines, leukocytes and endothelium. Reactive oxygen species and microcirculatory disturbances are also pivotal2. An understanding of the host's response to injury might enable us to modify it and prevent the development of organ dysfunction. IMMUNOACTIVATION Two models have been proposed for the exaggerated immunoinflammatory response3. According to the 'one hit' model, the initial massive tissue injury and shock gives rise to an intense systemic inflammation syndrome (SIRS) with remote organ injury. In the 'two hit' model, the initial SIRS is less intense and normally resolves but the patient is vulnerable to secondary inflammatory results that can reactivate the SIRS and precipitate late MOF ( Figure 1 ). This second insult may take many forms, among them sepsis and surgical procedures4. What components of the immune system are involved? Those implicated include proinflammatory cytokines, activated polymorphonuclear leukocytes and subsequent leukocyte endothelial-cell interactions5. The major cytokines participating in the response to trauma include tumour necrosis factor-oa (TNFa), interleukin-1 (IL-1), IL-2, IL-6 and IL-86.
Each cytokine mediates various effects and their actions
can be additive. TNF-a and IL-1 (p), produced mainly by monocytes, induce synthesis of acute phase proteins and increase the adhesiveness of leukocytes on vascular endothelium7. The serum of critically ill patients shows high concentrations of TNF-ca8-10, but in the early stages after injury the results have been mixed, ranging from undetectable1 1-14 to highI5 16. (The contradictions may be explained partly by the use of different sampling methods and assays.) In addition, some workers report the presence of high levels of naturally occurring inhibitors of TNF-a, known as soluble TNF receptors17, which compete with the membrane receptors for binding of free TNF-cx, thus downregulating any detrimental TNF bioactivity and making its detection in the peripheral circulation difficult18. The published work is clearer with regard to the release of IL-1, IL-2, IL-6 and IL-8; our group and others have detected high levels shortly after accidental trauma19-21. IL-6, in particular, is released rapidly after both surgical and accidental trauma22'23 and its concentration correlates with the degree of injury24.
Among the cellular elements in the inflammatory cascade, the polymorphonuclear leukocyte is regarded as the pivotal player. After activation it adheres to vascular endothelium, subsequently passing into the surrounding tissues where its proteolytic enzymes are released and cause tissue destruction26-28. To (receptors) known as integrins29,30. Normally, circulating leukocytes will not adhere to endothelial cells, and the process involves a corresponding activation of the endothelium, which expresses its own adhesion molecules namely, intracellular adhesion molecule-1 (ICAM-1) and E-selectin. These receptors can be stimulated by a variety of biological agents such as cytokines (TNF-a, IL-1, IL-8), bacterial peptides, complement fragments and endotoxin3l. E-selectin initiates and ICAM-1 completes the adhesion process that allows migration of the leukocyte across the vascular endothelium32 ( Figure 2 ). As this process takes place, soluble products of E-selectin and ICAM-1 are discarded into the circulation and can be detected peripherally. After migration, the tissue destruction mediated by neutrophils is partly due to release of elastase, a neutral proteinase stored in the azurophilic granules.
IL-6, soluble ICAM, soluble E-selectin and elastase can be measured in the peripheral blood by enzyme linked immunosorbent assays (ELISAs) while the activity of the CD 1 lb receptors can be determined by fluorescent labelling of living cells with monoclonal antibodies. Several groups have reported activation of leukocytes (upregulation of CD 1llb receptors and plasma elastase release), as well as release of adhesion molecules from the endothelial cells, after trauma33-36; and, again, the magnitude of these responses has correlated with the extent of injury37. Probably it is loss of control of this normal immunoinflammatory response that causes the widespread tissue destruction characteristic of ARDS and MOF. IMMUNOSUPPRESSION Although selective immunostimulation may thus play a critical part in the development of severe complications after injury, it is clear that the predominant effect of surgical or accidental trauma is immunosuppressive. Such immunosuppression is widely thought to contribute to infection and sepsis after trauma38. After injury, the production of immunoglobulins and interferon (IFN) falls and many patients become anergic as assessed by delayed hypersensitivity skin testing39. Defects in neutrophil chemotaxis, phagocytosis, lysosomal enzyme content and respiratory burst have also been reported40'41.
At the cellular level, much research has been focused on the HLA-DR locus, which mediates the processing of antigen to allow for cellular immunity and specific immune responses to infection42. The expression of major histocompatibility complex class II HLA-DR antigen on the surface of circulating monocytes, an index of antigen presenting cell capacity, is decreased after both surgical and accidental trauma43.
The decline and recovery of HLA-DR expression on monocytes relates closely to clinical outcome and may predict which patients will develop complications after trauma. In patients with uneventful recovery from severe trauma, monocyte HLA-DR expression returns to normal within a week; in those who develop sepsis but recover, it takes three weeks to return to normal levels; while in patients who develop sepsis and subsequently die, it never returns to normal4. The expression of HLA-DR on monocytes is one of the few indices of immunological reactivity that correlate well with morbidity and mortality from sepsis.
The mechanism for the downregulation of HLA-DR expression is not clear. between IL-10 gene expression and the fall in monocyte HLA-DR antigen expression in patients undergoing major abdominal surgery; thus postoperative immunosuppression might be mediated by IL-10. Perhaps measurement of this or other molecules will enable us to predict patient course and target our treatments more effectively.
BIOLOGICAL VARIATION IN DEVELOPMENT OF POST-TRAUMATIC COMPLICATIONS
Biological variation is increasingly cited as an explanation why some patients develop serious post-traumatic complications and others do not47. It seems that biological variation influences the outcome from any form of traumatic insult. For example, polymorphism within the TNF genotype determines whether TNF responses to a standard endotoxin dose are high or low48. Genetic polymorphism of the neutrophil receptor for immunoglobulin G, CD16, has also been reported and is associated with functional differences in neutrophil phagocytosis49.
Inherited traits towards high or low levels of HLA-DR expression are further evidence of a genetic component in immune response to injury45. Lately, our group has been able to correlate the decrease in HLA-DR expression on monocytes with the pulmonary shunt, a preclinical component of ARDs, and has hypothesized a link between this potentially inherited cellular mechanism and the clinical syndrome of ARDS50. CONCLUSION Both stimulation and suppression of the inflammatory system are normal responses to injury, but exaggeration of either can lead to serious complications. Molecular biology is providing us with new therapeutic targets and the potential to approach the treatment of diseases from new directions. Unfortunately, specific molecular treatments to block uncontrolled and harmful responses to injury have been disappointing to date51'52, for reasons that may include the difficulty of identifying patients who would benefit from such therapies, the targeting of only one or two molecules in complex inflammatory cascades and our lack of understanding of fundamental disease processes. As knowledge increases, one day it may be possible to identify the individuals at particular risk and then to block the harmful responses to injury.
